Edit
NeuroKaire (formerly GenetikaPlus)~
https://www.neurokaire.com/Last activity: 30.07.2026
Active
NeuroKaire (formerly GenetikaPlus) is pioneering a personalized treatment approach for psychiatric and neurological conditions, transforming the way these diseases are treated and new drugs are discovered.
Total raised: $10M
Investors 2
| Date | Name | Website |
| 29.05.2024 | Jumpspeed ... | jumpspeed.... |
| 14.09.2024 | Jumpspeed ... | jumpspeed.... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 17.12.2024 | - | $10M | - |
Mentions in press and media 4
| Date | Title | Description |
| 30.07.2026 | Mindful Care Partners with NeuroKaire to Bring Brain Biology into Antidepressant Prescribing | NeuroKaire’s BrightKaire test will be part of routine care across Mindful Care’s clinics so clinicians can support smarter prescribing decisions KEARNY, NJ, UNITED STATES, July 30, 2026 /EINPresswire.com/ -- Mindful Care, a hybrid therapy a... |
| 17.06.2026 | 1 in 5 Depressed Americans Are Self-Medicating With Screens, Cannabis, Weight-Loss Drugs & More, New Report Finds | NeuroKaire's 'Self-Medication Generation' Report (18,000+ responses) Finds Americans Are Doing More to Treat Themselves Than The System Is Doing to Treat Them KEARNY, NJ, UNITED STATES, June 17, 2026 /EINPresswire.com/ -- One in five Americ... |
| 17.12.2024 | NeuroKaire Grabs $10M | KEARNY, NJ, NeuroKaire, a pioneering biotechnology company specializing in precision medicine in psychiatry and neurology, has successfully secured $10 million in funding. >> Click here for more funding data on NeuroKaire >> To... |
| 17.12.2024 | NeuroKaire Raises $10M in Funding | NeuroKaire, a Kearny, NJ-based biotechnology company specializing in precision medicine in psychiatry and neurology, raised $10M in funding. The round was led by GreyBird Ventures, with participation from Meron Capital, Jumpspeed Ventures. ... |